Sökning: onr:"swepub:oai:DiVA.org:uu-329638" >
Oncolytic alphaviru...
-
Martikainen, MiikaUppsala universitet,Science for Life Laboratory, SciLifeLab,Institutionen för immunologi, genetik och patologi,Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, Kuopio 70211, Finland
(författare)
Oncolytic alphavirus SFV-VA7 efficiently eradicates subcutaneous and orthotopic human prostate tumours in mice
- Artikel/kapitelEngelska2017
Förlag, utgivningsår, omfång ...
-
2017-05-30
-
NATURE PUBLISHING GROUP,2017
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-329638
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-329638URI
-
https://doi.org/10.1038/bjc.2017.151DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Background: Despite recent therapeutic and diagnostic advances, prostate cancer remains the second leading cause of cancer-related deaths among men in the Western world. Oncolytic viruses that replicate selectively in tumour cells represent a novel treatment candidate for these malignancies.Methods: We analysed infectivity of avirulent Semliki Firest virus SFV-VA7 in human prostate cancer cell lines VCaP, LNCaP and 22Rv1 and in nonmalignant prostate epithelial cell line RWPE-1. Therapeutic potency of SFV-VA7 was evaluated in subcutaneous and orthotopic mouse LNCaP xenograft models.Results: SFV-VA7 infected and killed the tested human prostate cancer cell lines irrespective of their hormone response status, while the nonmalignant prostate epithelial cell line RWPE-1 proved highly virus resistant. Notably, a single peritoneal dose of SFV-VA7 was sufficient to eradicate all subcutaneous and orthotopic LNCaP tumours.Conclusions: Our results indicate that SFV-VA7 is a novel, promising therapeutic virus against prostate cancer warranting further testing in early clinical trials.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Ruotsalainen, JanneUniv Eastern Finland, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, Kuopio 70211, Finland.;Univ Hosp Magdeburg, Dept Dermatol, D-39120 Magdeburg, Germany.
(författare)
-
Tuomela, JohannaUniv Turku, Inst Biomed, FIN-20520 Turku, Finland.
(författare)
-
Harkonen, PirkkoUniv Turku, Inst Biomed, FIN-20520 Turku, Finland.
(författare)
-
Essand, MagnusUppsala universitet,Science for Life Laboratory, SciLifeLab,Institutionen för immunologi, genetik och patologi(Swepub:uu)magnessa
(författare)
-
Heikkila, JariAbo Akad Univ, Dept Biochem & Pharm, Turku 20500, Finland.
(författare)
-
Hinkkanen, AriUniv Eastern Finland, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, Kuopio 70211, Finland.
(författare)
-
Uppsala universitetScience for Life Laboratory, SciLifeLab
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:British Journal of Cancer: NATURE PUBLISHING GROUP117:1, s. 51-550007-09201532-1827
Internetlänk
Hitta via bibliotek
Till lärosätets databas